You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR PRAZIQUANTEL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PRAZIQUANTEL

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00215267 ↗	The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	Completed	Ministry of Health, Uganda	N/A	2005-09-01	The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00215267 ↗	The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	Completed	DBL -Institute for Health Research and Development	N/A	2005-09-01	The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	Durban University of Technology	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	Durban University of Technology South Africa	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	DBL -Institute for Health Research and Development	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PRAZIQUANTEL

Condition Name

Chart
Table

Condition Name for PRAZIQUANTEL
Intervention	Trials
Schistosomiasis	15
Healthy	8
Malaria	5
Schistosoma Mansoni	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PRAZIQUANTEL
Intervention	Trials
Schistosomiasis	26
Schistosomiasis haematobia	8
Malaria	7
Schistosomiasis mansoni	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PRAZIQUANTEL

Trials by Country

Map
Table

Trials by Country for PRAZIQUANTEL
Location	Trials
Uganda	6
Tanzania	6
Germany	5
Gabon	3
Kenya	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PRAZIQUANTEL
Location	Trials
Maryland	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PRAZIQUANTEL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PRAZIQUANTEL
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	11
Phase 2/Phase 3	4
[disabled in preview]	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PRAZIQUANTEL
Clinical Trial Phase	Trials
Completed	36
Recruiting	6
Not yet recruiting	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PRAZIQUANTEL

Sponsor Name

Chart
Table

Sponsor Name for PRAZIQUANTEL
Sponsor	Trials
DBL -Institute for Health Research and Development	8
Merck KGaA, Darmstadt, Germany	6
Merck KGaA	5
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PRAZIQUANTEL
Sponsor	Trials
Other	85
Industry	21
NIH	7
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.